Myopia Control With a Innovative Spectacle Lens - A Cessation Study

Clinical Evaluation of A Innovative Spectacle Lens in Slowing Myopia Progression - A Cessation Study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06884527

Enrollment

Registered

2025-03-19

Start date

2025-02-18

Completion date

2026-11-01

Last updated

2026-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia Progressing

Brief summary

The purpose of this study is to quantify myopic progression following cessation of a innovative spectacle lenses after 3 years' use.

Interventions

DEVICESingle Vision Lens to A innovative spectacle lens

Participants in this arm are from the test group of the previous clinical trial (NCT05174780), where they wore the innovative spectacle lenses for three years. They will now wear single vision lenses for 12 months.

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

9 Years to 15 Years

Healthy volunteers

Yes

Inclusion criteria

* Existing subjects from the NCT05174780 clinical study. * Ability to comply with study procedures. * Informed consent of parent/guardian and assent of subject.

Exclusion criteria

* Current ocular infection, inflammation, or irritation likely to affect vision.

Design outcomes

Primary

Measure	Time frame
Change in cycloplegic spherical equivalent refraction from baseline	0 - 12 months
Change in Axial Length from baseline	0 - 12 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 12, 2026